Obstetric Cholestasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

Mirum Pharmaceuticals Initiates Phase 3 Clinical Trial of Maralixibat for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
FOSTER CITY, Calif., July 9, 2019 /PRNewswire/ -- Mirum Pharmaceuticals today announced the dosing of the first patient in the Phase 3 MARCH-PFIC clinical trial of its lead drug candidate, maralixibat, in pediatric patients with... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 9, 2019 Category: Pharmaceuticals Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC) Interventions:   Drug: Maralixibat;   Other: Placebo Sponsor:   Mirum Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2019 Category: Research Source Type: clinical trials